(Reuters) -Telehealth firm Hims & Hers Health ( HIMS ) said on Monday it plans to sell Eli Lilly's ( LLY ) weight-loss drug Zepbound on its platform.
Shares of the company were up 8.5% in afternoon trading.
(Reporting by Sneha S K in Bengaluru; Editing by Arun Koyyur)